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Abstract
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are poorly
understood. In contrast to the well documented inhibition of long-term potentiation (LTP) in CA3-CA1 synapses
by acute Aβ application in adult neurons from rodents, young amyloid precursor protein (APP) transgenic
mouse models often, surprisingly, show normal LTP. This suggests that there may be important differences
between mature-onset and developmental-onset APP expression/ Aβ accumulation and the ensuing synaptic
and behavioural phenotype. Here, in agreement with previous studies, we observed that developmental
expression of APPSw,Ind (3–4 month old mice from line 102, PLoS Med 2:e355, 2005), resulted in reduced basal
synaptic transmission in CA3-CA1 synapses, normal LTP, impaired spatial working memory, but normal spatial
reference memory. To analyse early Aβ-mediated synaptic dysfunction and cognitive impairment in a more
mature brain, we used controllable mature-onset APPSw,Ind expression in line 102 mice. Within 3 weeks of
mature-onset APPSw,Ind expression and Aβ accumulation, we detected the first synaptic dysfunction: an
impairment of LTP in hippocampal CA3-CA1 synapses. Cognitively, at this time point, we observed a deficit in
short-term memory. A reduction in basal synaptic strength and deficit in long-term associative spatial memory
were only evident following 12 weeks of APPSw,Ind expression. Importantly, the plasticity impairment observed
after 3 weeks of mature-onset APP expression is reversible. Together, these findings demonstrate important
differences between developmental and mature-onset APP expression. Further research targeted at this early
stage of synaptic dysfunction could help identify mechanisms to treat cognitive impairment in mild cognitive
impairment (MCI) and early AD.
Introduction
Direct evidence from studies of the human brain sug-
gests that hippocampal shrinkage [24] and synapse loss
[18, 52] occur early in the pre-symptomatic and MCI
phases of AD. Intervention at these early stages is
becoming increasingly attractive from a therapeutic
point of view as there is the potential to remove disease
triggers and halt neurodegeneration prior to overt
memory loss [28].
Human studies have provided a strong causal link
between APP cleavage/Aβ production and the manifestation
of AD [30]. Aβ can have potent synaptotoxic effects acutely
or chronically in a wide variety of research models [7]. Acute
Aβ application to neurons in culture or brain slices is suffi-
cient to drive synaptic impairment within minutes to hours
[14, 45, 55, 56, 66], and short-term exposure to Aβ in vivo
can cause both synaptic and cognitive dysfunction in ro-
dents within hours to days [11, 15, 41, 57].
Transgenic APP models allow for the analysis of chronic
Aβ exposure and brain accumulation that could lead to a
better understanding of the emergence and progression of
cognitive impairment in AD. However, to date, animal
research in AD has not led to a therapy and it is essential
to continue the refinement of animal models to translate
pre-clinical studies into relevant knowledge that can result
in a disease modifying strategy. The vast majority of
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available AD mouse models express proteins with familial
disease-causing mutations starting from embryonic or
early postnatal development, and can thus be considered
as developmental-onset models of AD. For example in the
J20 line the PDGF promoter driven expression of APPS-
w,Ind starts at embryonic day 15 (E15) [51], in the Tg2576
line the PrP promoter driven expression of APPSw starts
at E12 [1], and in the TASTPM line the Thy1 promoter
driven expression of APPSw and Psen1 M146V start at
postnatal day 7 (P7) [12].
The use of these developmental-onset AD models
raises a number of key issues. Firstly, intrinsic APP is
developmentally expressed [21] and promotes synapse
formation [68] and neuronal migration [72], and the fur-
ther consequences of overexpressing mutant APP during
development are still unclear. Secondly, differences in
composition of glutamatergic synapses [36, 38] between
developing and more mature mice can affect their re-
sponses to Aβ. For example LTP is affected by acute Aβ
exposure in juvenile (P16–28), but not in postnatal
(P8-P9) mouse hippocampal circuits [62]. Following
developmental expression of Aβ in embryonic or postna-
tal animals, it is unknown whether compensatory effects
make these circuits resilient to chronic Aβ exposure.
Thus, overexpression of APP during development may
cause complex and confounding effects on the observed
phenotype. Thirdly, most behavioural tests cannot be
performed in immature mice (e.g. younger than 6
weeks) and therefore it has not been possible to assess
memory in young mice with developmental-onset of
Aβ accumulation.
To investigate the emergence of both synaptic and
cognitive impairments following Aβ accumulation in
mice, we used the line 102 model, an inducible Tet-Off
transgenic model that can be analyzed either as a
developmental-onset AD model [35], or as an inducible
AD model. Following previous work [23] we induced
APP expression at 6 weeks of age –once key develop-
mental processes have largely taken place; e.g. the
peaks of neurogenesis and myelination rate have passed
[20, 53]. Furthermore, post-natal changes in expression
of synaptic proteins have largely stabilized [29] includ-
ing GluN2A and GluN2B protein expression [36]. We
thus refer to this model as mature-onset APP
expression. Using electrophysiological, biochemical and
behavioral analyses we characterized the emergence of cog-
nitive and synaptic dysfunction in both developmental-on-
set and mature-onset versions of the line 102 model.
Mapping the emergence and progression of deficits in
synaptic function and cognition in this mouse model will
help define the mechanisms underpinning memory loss as a
consequence of rising levels of Aβ species and serve as a




Animal care and experimental procedures were con-
ducted in accordance with UK Home Office regula-
tions under the Animals (Scientific Procedures) Act of
1986. Mice were housed in groups of 2 to 6, under a
12/12 h light (6 am-6 pm)/dark(6:01 pm-5:59 am) cycle
at 21 °C, with food and water ad libitum. All efforts
were made to minimize experimental animal numbers.
Transgenic APP and tTA mice from mouse line
tetO-APPswe/ind (line 102) were generously provided
by Joanna Jankowsky, Baylor School of Medicine. APP
mice contained the chimeric mouse APP695 gene with
a humanized Aβ domain containing the Swedish (APP
KM670/671NL) and Indiana (APP V717F) mutations
(APPSw,Ind) driven by the tetO promoter while tTA
mice contained the tetracycline transactivator (tTA)
gene under the control of the CaMKIIα promoter. The
colony was maintained by crossing single transgenic
tTA and APP mice. The age of mice analyzed ranged
from 6 to 35 weeks analysed with age-matched controls
as indicated in each section. Following our observa-
tions of identical performance in the Morris water
maze (Fig. 1b-d) for WT and single transgenic (APP or
tTA) mice, these control genotypes were treated
equally in all other tests. To control for age and sex
effects, in each experiment littermate matched pairs
were used and each matched pair consisted of a double
transgenic APP/tTA mouse (expressing APP) and a
single transgenic (control genotypes: WT, APP or tTA)
of the same sex whenever possible (88% of our
matched pairs were of the same sex), and overall we
used 52% females, 48% males. The experimenter was
blind to mouse genotype throughout all experimental
procedures and data analysis.
Doxycycline administration
Following [35], APPSw,Ind expression was suppressed by
feeding doxycycline (dox) containing chow to pregnant
females and females with litters, and later on weaning
pups onto the dox diet. We used a high dose of dox
(625 mg/kg, TestDiet Limited) given that we observed
mild hyperactivity and weight loss in pilot experiments
in double transgenics at 200 mg/kg possibly owing to
enhanced transgene leakage (data not shown). At 6
weeks of age, the diet was switched to normal chow
(RM-1, Special Diet Services, UK) to initiate APPSw,Ind
expression and these animals are referred to as mature-
onset mice. To achieve developmental-onset APP
expression, breeding pairs and weaned mice were fed
normal chow and mice were analyzed between 8 and
12 weeks of age.
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Acute brain slice preparation and electrophysiology
Following [56], mice were anaesthetised using isoflurane
and decapitated. The brain was quickly extracted and
submerged in artificial cerebrospinal fluid (aCSF) ~ 300
mOsm containing 126mM NaCl, 2 mM CaCl2, 10 mM
glucose, 2 mM MgSO4.7H2O, 3 mM KCl, 1.25 mM
NaH2PO4.2H2O and 26.4 mM NaHCO3 bubbled with
carbogen gas (95% O2, 5% CO2). Sagittal brain slices of
400 μm thickness were cut in ice-cold ACSF solution
using a vibrating microtome (Campden Instruments,
7000 smz2). In older animals (29-weeks-off-dox group),
1 mM kynurenic acid was added to the ACSF during
slicing to improve slice viability [22]. All slices were
transferred to a submerged-type holding chamber and
incubated in oxygenated ACSF at room temperature for
approximately 60 min as a slice recovery period. Slices
were then transferred to the recording interface chamber
where they were continuously perfused with oxygenated
ACSF at 30 °C with a flow rate of about 2 ml/min. Slices
were allowed to recover in the interface chamber for a
further 60min before any recordings were made. Field exci-
tatory postsynaptic potentials (fEPSPs) were recorded in the
CA1 stratum radiatum, using glass microelectrodes filled
with ACSF, in response to stimulation of the Schaffer collat-
eral pathway using 50 μs pulses delivered via a stainless-steel
electrode. Synaptic strength was assessed by generating
Fig. 1 Developmental onset APP/tTA mice display impaired spatial working but normal spatial reference memory. a Developmental onset APP/tTA mice
showed reduced spontaneous alternation in the T-maze (control mean= 81.4 ± 2.8, n= 9; APP/tTA mean= 65.8 ± 5.4, n = 9). Dashed line represents
chance level of performance of 50%. b Developmental onset APP/tTA mice exhibited impaired performance on the Morris water maze, as evidenced by
longer latency to platform scores compared to control WT, tTA and APP mice (WT n= 10, tTA n = 8, APP n = 9, APP/tTA n= 15). * WT vs. APP/tTA, % tTA
vs. APP/tTA, & APP vs. APP/tTA. c Probe trial performed at the end of MWM testing showed a significant difference in time spent within the target
quadrant. Control groups, but not APP/tTA, performed significantly better compared to chance performance of 25% (dashed line; WT mean = 42.5 ± 4.7;
tTA mean = 48.2 ± 6.8; APP mean = 48.4 ± 5.65; APP/tTA mean = 28.6 ± 5.10). d Thigmotaxis analysis, measuring time spent within maze perimeter,
showed that developmental onset APP/tTA mice were more thigmotaxic compared to control littermates. * WT vs. APP/tTA, % tTA vs. APP/tTA, & APP vs.
APP/tTA. e Developmental onset APP/tTA mice showed normal spatial reference memory acquisition on the Y-water maze (control n= 6, APP/tTA n = 6).
Dashed line represents chance level of performance of 50%. f Developmental onset APP/tTA mice were not significantly different from control littermates
during probe trial testing (control mean = 58.8 ± 3.65; APP/tTA mean = 54.5 ± 8.97). Dashed line represents chance level of performance of 33.3%
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input-output (I-O) curves assessing the initial slope of the
rising phase of the average fEPSP (N= 3 repetitions) in re-
sponse to stimulation strengths ranging from 20 to 200 μA.
Higher stimulation amplitudes or repetitions were not used
to avoid induction of plasticity changes. Stimulation was
subsequently set to a value that elicited a fEPSP of ~ 40% of
the maximum fEPSP amplitude to allow for enhancement
of the response without spiking after LTP. Paired-pulse fa-
cilitation (PPF) was assessed with a pair of stimuli delivered
at an inter-stimulus interval of 40ms. The PPF ratio of the
resulting average fEPSP waveform (N= 3 repetitions) was
calculated by dividing the amplitude of the second fEPSP re-
sponse by the amplitude of the first. Example traces for I-O
curves and PPF are the average of 3 individual responses.
Baseline response for long term potentiation (LTP)
was obtained by stimulating the Schaffer collateral path-
way every 10 s and recording the fEPSP slope for a mini-
mum of 30min. Once a stable baseline was observed,
LTP was induced using a theta burst stimulation para-
digm (TBS) [47], made up of three trains separated by
15 s. Each train was composed of ten bursts at 5Hz, each
burst containing four pulses at 100Hz. fEPSP slopes were
normalised to the last 10min of baseline average. LTP value
was calculated by averaging fEPSPs 50–60min after LTP
induction. Example traces for LTP are the average of 6 indi-
vidual responses.
The criterion for inclusion of I-O and PP data was the
presence of an EPSP with a distinguishable volley upon
stimulation of the Schaffer collaterals. If the EPSP was
stable for the duration of the LTP baseline, then LTP
was induced and measured. The number of LTP experi-
ments to be performed was limited due to the overall
time window of acute brain slice integrity (we recorded
for ~ 8 h after dissection). Overall, for IO curves and PP
data we used an average of 5.10 ± 1.93 slices per mouse,
and for LTP an average of 2.63 ± 0.63 slices per mouse.
Data from different slices from one animal were aver-
aged and the average of those slices was counted as N =
1. All mice used for electrophysiology were experimen-
tally naïve (i.e. they had not been used previously in the
behavioural tasks described below).
Behavioural assays
Behavioural assays were performed in developmental-onset
or mature-onset mice. Developmental-onset mice were fed
normal diet throughout their lifespan. Mature-onset mice
were bred on doxycycline diet for 6 weeks and then
switched to normal diet to “switch on” the APPSw,Ind trans-
gene for 2, 3 or 12 weeks as indicated in each section below.
Some tests were performed in mice maintained on the dox
diet throughout to test for the potential impact of transgene
leakage as indicated in each section. All tests were done in
experimentally naïve mice.
Spontaneous alternation in the T-maze
An enclosed T-maze of grey UPVC (30 cm long, 10 cm
wide, 20 cm high) with sliding guillotine-type doors present
at the arm entrances was used [17]. Each trial consisted of
two consecutive runs; a trial run and a choice run. During
the trial run the mouse was placed at the end of the start
arm and allowed to enter either goal arm by choice, where
it was then confined for 30 s by sliding down the door.
Following this, the mouse was immediately removed from
the maze. With both doors open, the mouse was placed in
the start arm for the choice run. The alternation criterion
was for the mouse to enter the opposite goal arm during
the choice run (scoring 1 in such case, and 0 if it entered
the same arm). Each mouse was tested with four trials per
day with a minimum inter-trial interval of 30min. 20 trials
were performed in total over five consecutive days. The al-
ternation score was the average score across the 20 trials.
Different groups of mice were tested at 2, 3 and 12 week-
s-off-dox. To test transgene leakage, 12-week-old mice that
were bred on dox throughout their life were also tested.
Morris water maze (MWM)
Following [2], mice were trained in a water maze filled
with opaque water maintained between 21 and 23 °C. We
used two different mazes, one with a diameter of 2 m (Fig.
1b-d, Fig. 5c-e, Oxford) and one with a diameter of 1.2 m
(Fig. 5a-b, Southampton); the platform with a 15 cm or 10
cm diameter, respectively, was kept submerged 1.5 cm
below the water level. Trials were conducted over a
two-week period. Acquisition training was performed dur-
ing the first four days of each week and consisted of four
trials a day with an inter-trial interval of 15 s. The mouse
was placed facing the wall at one of the eight randomly al-
located start locations and given 90 s to locate the hidden
platform. If they failed to locate the platform within this
time limit, they were guided to the submerged platform.
Once on the platform, all mice spent 30 s on it before be-
ing removed from the water. A probe trial was performed
at the end of week two. During the probe trial, the plat-
form was removed and the mouse was given 60 s to swim
freely in the maze. Thigmotaxis (defined here as an in-
creased tendency to swim closer to the sidewall) was mea-
sured by assessing the time spent within 20 cm of the
outer perimeter of the water maze (Figs. 1d and 5e). Etho-
vision video tracking system was used to acquire and ana-
lyse data. Developmental-onset mice were tested at 9–14
weeks. All other mice tested in the MWM were 8 weeks
old, either bred on dox throughout to test transgene leak-
age or taken off the dox diet at 6 weeks of age to allow 2
weeks APPSw,Ind expression.
Water escape Y-maze task (Y-water maze)
The apparatus consisted of an enclosed Y-maze made of
clear Perspex with three arms (30 cm long, 8 cm wide,
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20 cm high walls) separated by 120° [2]. The Y-water
maze was filled with opaque water maintained between
21 and 23 °C and a platform with a diameter of 7 cm was
kept submerged 1.5 cm below the water level. The plat-
form was placed in a fixed location defined by the allo-
centric, extra-maze cues, at the end of one of the three
arms (goal arm), which was counterbalanced across the
different mouse groups. At the beginning of each trial,
the mouse was placed at one of the two remaining arms
(start arms). The order of start arm was varied pseudo-
randomly across trials for each mouse (with no more
than 2 consecutive starts from the same arm and equal
numbers of starts from the arm to the left and right of
the target arm in each block of trials) and was also
counterbalanced across groups. The mouse was allowed
to move freely around the maze until it reached the
hidden platform. If the mouse did not reach the plat-
form by 90 s it was guided to the platform. The mouse
was allowed to remain on the platform for 30 s before
being removed from the water maze. The first 9 days of
testing involved acquisition training and consisted of
five trials a day with an inter-trial interval of 15 s. For
each trial, the first choice (first arm entered) was recorded
and a score of 1 was given if the mouse entered the arm
containing the platform first and a score of 0 given if it en-
tered the other arm or re-entered the start arm. An arm
entry was defined when a mouse placed all four paws into
one of the goal arms. Performance for each individual ani-
mal was expressed as a percentage of correct first choices
on each daily block of trials. On day 10, a probe trial was
performed, where the platform was removed and the
mouse was allowed to swim freely for 60 s. The percentage
time spent in each arm was calculated during this probe
trial. Ethovision video tracking system was used to acquire
and analyse data. Mice were tested at 2, 3, and 12
weeks-off-dox.
Tissue collection and homogenization
Mice from 6 to 18 weeks of age were terminally anesthe-
tised with intraperitoneal injection of sodium pentobarbital
and transcardially perfused with ice cold heparinised saline
(0.9% saline containing 5000U/L heparin). The brain was
then carefully dissected and hemisected. The cortex and
hippocampus were dissected and snap frozen on dry ice.
Frozen hippocampal samples were lysed as previously
described [23] and lysates were diluted at 2.5 mg/ml.
Western blotting
15 μg of the resulting homogenate from above was sepa-
rated on a 10% SDS-PAGE gel and transferred to nitrocel-
lulose membrane. Membranes were blocked in TBS plus
0.1% Tween-20 and 5% dried skimmed milk for one hour.
Membranes were probed overnight at 4 °C in the APP anti-
body 6E10 (1:11000; SIG-39320, BioLegend/ Covance) and
GAPDH (1:11000; 5174, Cell Signalling) in 5% BSA and
TBS plus 0.1% Tween-20. Membranes were then washed
and probed with fluorescent secondary antibody, goat
anti-mouse 800 (1:10,000, LICOR:926–32,210) and/or goat
anti-rabbit-680 (1:10,000, LICOR:926–68,021), in 5% dried
skimmed milk and TBS plus 0.1% Tween-20 and imaged
using Odyssey CLx Infrared Imaging system (LICOR).
Amyloid beta measurement
The Multispot ELISA (Mesoscale Discovery, Rockville,
MD, V-PLEX Aβ Peptide Panel (6E10) Kit) was used to
determine the concentration of Aβ peptide in mouse
brain lysates. To maintain SDS concentrations at ≤0.1%
SDS as per manufacturer’s instructions, the 2.5 mg/ml
lysates prepared above were diluted 1:20 using Diluent
35 supplied by the manufacturer.
Data analysis
Statistical significance was assessed with one-way,
two-way or repeated measures (RM) ANOVA as indi-
cated, followed by post-hoc analysis with Sidak’s correction
except for Fig. 1 (APP and Aβ levels) where Fisher least
significant difference was employed. In all statistical ana-
lyses, results N equals the number of mice (i.e. data from
different slices from the same animal were averaged and
counted as N = 1). All data are presented as mean ± SEM.
Student’s t-tests were two-tailed and unpaired. Significant
pairwise comparisons are highlighted within figures as
follows: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Results
Developmental-onset of expression of APPSw,Ind in line
102 mice results in cognitive impairment, diminished
basal synaptic function but normal CA3-CA1 LTP
First, to assess the phenotype of developmental-onset
line 102, we analyzed mice bred in the absence of dox,
so that APP expression driven by the CaMKIIα pro-
moter commenced around P5 [6]. We tested spatial
working memory using spontaneous alternation in the
T-maze and found a significant impairment in APP/tTA
mice which produce APP following Tet-Off activation of
the promoter by tTA in the absence of dox (Fig. 1a;
t-test: t(16) = 2.58, p = 0.02). To assess spatial reference
memory, we first used the Morris water maze. We ana-
lyzed all four genotypes of this transgenic mouse line:
the three control genotypes: WT, tTA, APP and the
affected genotype APP/tTA, and observed a substantial
impairment in latency during acquisition in the double
transgenic APP/tTA mice (Fig. 1b; RM ANOVA: geno-
type F(3,40) = 20.09, p < 10
− 4; training block F(7,280) =
23.24, p < 10− 4; genotype x training block F(21,280) = 3.31,
p < 10− 4). A similar pattern of results was observed for
path lengths (data not shown; RM ANOVA: genotype
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F(3,40) = 15.5, p < 10
− 4; training block F(7,280) = 17.96, p <
10− 4; genotype x training block F(21,280) = 2.84, p < 10
− 4).
We also observed a significant effect of genotype in
the time spent in the platform quadrant during the
probe trial (Fig. 1c; one-way ANOVA: F(3,40) = 3.16, p =
0.035), with APP/tTA mice performing close to chance
levels of 25% (t-test: t(22) = 0.55, p = 0.59), while the three
control groups performed significantly better than
chance (t-test: WT t(17) = 3.50, p = 0.0028; tTA t(17) =
3.24, p = 0.0048; APP t(16) = 4.14, p = 0.0008).
However, closer inspection and analysis of these data re-
vealed pronounced thigmotaxis in APP/tTA mice
throughout the MWM testing (Fig. 1d; RM ANOVA:
genotype F(3,40) = 30.29, p < 10
− 4; training block F(7,280) =
54.26, p < 10− 4; genotype x training block F(21,280) = 5.07,
p < 10− 4), which followed a highly similar pattern to la-
tency scores. Thus, although the impaired performance in
the MWM is similar to that reported in many other APP
models [48, 69], it is not possible to ascertain in our mice
whether there is a genuine learning deficit is present in
this behavioural paradigm. Indeed it is unclear whether
the thigmotaxic behaviour that we observed in the MWM
is a cause or a consequence of the spatial learning deficit
in the developmental-onset 102 model. It is possible that
the increase in thigmotaxis reflects a lack of engagement
with this behavioural task (i.e. searching for the hidden
platform) that could signal a phenotype unrelated to
spatial memory, but which nevertheless appears like a
spatial learning deficit. Alternatively, the increase in thig-
motaxic behaviour in the developmental-onset mice could
reflect a default strategy given an inability to learn about
the spatial location of the platform.
To resolve this issue, we used an alternative water maze
task in which differences in thigmotaxis would not con-
found the results. We used a hippocampal-dependent,
swim-escape version of the Y-maze task (Y-water maze)
which we have shown previously is robustly impaired by
hippocampal lesions [43] and hippocampal GluN1 subunit
ablation [2]. Mice were trained to locate a hidden escape
platform which was situated consistently at the end of one
of the goal arms, as defined by the extra-maze spatial cues.
We assessed whether the mouse’s first choice was to enter
the arm containing the escape platform (correct choice)
and expressed this measure as the percentage of correct
choices per block (see Methods). After the final block of
training, we measured retention of memory by conducting
a probe trial during which the platform was removed from
the maze and the time spent in each of the maze arms
was quantified. Surprisingly, spatial reference memory in
the Y-water maze was comparable between APP/tTA mice
and control littermates both during acquisition (Fig. 1e;
RM ANOVA: genotype F(1,10) = 0.65, p = 0.44; training
block F(7,70) = 10.89, p < 10
− 4; genotype x training block
F(7,70) = 0.44, p = 0.87) and the probe trial (Fig. 1f; t-test:
t(10) = 0.52, p = 0.52). Thus, using a task that is much less
likely to be confounded by thigmotaxis, we show that
developmental-onset 8–12 week-old APP/tTA exhibit nor-
mal associative spatial reference (long-term) memory in
contrast to their impaired spatial working (short-term)
memory.
Next, to analyze hippocampal synaptic function in
developmental-onset APP/tTA mice, we first obtained I-O
curves at CA3-CA1 synapses in hippocampal slices and
observed a significant impairment in APP/tTA mice com-
pared to control littermates (Fig. 2a; RM ANOVA: geno-
type F(1,28) = 7.35, p = 0.011; stimulation F(7,196) = 80.98, p
< 10− 4; genotype x stimulation F(7,196) = 7.24, p < 10
− 4),
similar to that observed in other age-matched APP models
[31, 33]. We also found reduced paired pulse responses in
APP expressing mice (Fig. 2b; t-test: t(26) = 2.86, p =
0.0083), consistent with previous observations in young
TASTPM mice [16].
Interestingly, however, similar levels of TBS-induced LTP
responses were observed between developmental-onset
APP/tTA and control mice (Fig. 2c-d; t-test: t(22) = 0.37, p
= 0.72). These results are in agreement with previous ob-
servations showing normal CA3-CA1 LTP in young adult
APP transgenics including APP/PS1 [26, 27], J20 [42], and
Tg2576 mice [13, 19]. Thus, the behavioural and CA3-CA1
synaptic phenotype of developmental-onset line 102 APPS-
w,Ind mice is highly similar to that previously observed in
other young APP transgenic models that also express APP
from embryonic and/or postnatal development.
Rapid increase of APP expression and Aβ levels in
mature-onset APP/tTA mice
To analyze the impact of mature-onset APP expression in
line 102 mice, we raised mice on a dox diet until 6 weeks
of age (referred to as time 0). Then, mice were switched to
a normal chow for either 3 days, 2 weeks, 3 weeks or 12
weeks (referred to as time-off-dox, Fig. 3a). We used West-
ern blots to measure hippocampal APP expression for each
of the four genotypes (Fig. 3b). As expected, we observed a
rapid and significant increase in APP expression in APP/
tTA mice following dox withdrawal (Fig. 3b-c; two way
ANOVA: genotype F(1,50) = 71.98, p < 10
− 4; time-off-dox
F(4,50) = 23.26, p < 10
− 4; genotype x time-off-dox F(4,50) =
22.98, p < 10− 4). Post-hoc tests showed significantly higher
levels of APP expression for APP/tTA mice at all tested
time points, which peaked after 2 weeks-off-dox (Fig. 3b-c).
A faint APP transgene “leakage” band was observed in
APP/tTA mice that remained on dox (0 days). This band
was, however, significantly enhanced after APP/tTA mice
were taken off the dox diet for 3 days (Fig. 3b-c; p = 0.004).
In addition, an APP band was also observed in single
transgenic APP mice, in the absence of the tTA trans-
gene, and did not change across the different time
points tested (Fig. 3b). Importantly, single transgenic
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APP mice performed as well as WT and tTA controls
in the MWM (Fig. 1b-d). This is consistent with previ-
ous work with tTA-driven mouse models where
minimal transgene expression (“leakiness”) has been
observed in single transgenic APP mice [31] with no
effect on the phenotype.
We next examined whether there were APP expres-
sion differences between the mature-onset mice and
developmental-onset APP mice described in the previ-
ous section. We compared APP levels in 12 weeks-off--
dox mice (mature-onset, 18 weeks of age), against the
12-week-old developmental-onset mice (Fig. 3a), thus
matching for length of expression (Fig. 3b-c). There
was no significant difference in the APP expression
levels between APP/tTA developmental-onset vs
mature-onset APP/tTA mice (t-test: t(4) = 1.3, p = 0.25).
In order to assess Aβ levels we used an immunoassay
(Mesoscale platform) (Fig. 3d-e) and found a significant
increase in both Aβ40 (Fig. 3d; two way ANOVA: geno-
type F(1,54) = 77.8, p < 10
− 4; time-off-dox F(4,54) = 12.98, p <
10− 4; genotype x time-off-dox F(4,54) = 14.92, p < 10
− 4) and
Aβ42 (Fig. 3e; two way ANOVA: genotype F(1,54) = 76.01, p
< 10− 4; time off dox F(4,54) = 20.65, p < 10
− 4; genotype x
time-off-dox F(4,54) = 19.5, p < 10
− 4) in APP/tTA mice fol-
lowing dox withdrawal. Post-hoc tests showed that Aβ40
levels in APP/tTA mice at time 0 were comparable to con-
trols (Fig. 3d; t-test: t(10) = 0.42, p = 0.68), whereas Aβ42
levels were approximately three-fold higher than baseline
levels (Fig. 3e; t-test: t(10) = 2.3, p = 0.044) which is consist-
ent with the APP leakage described above. A steep increase
was observed thereafter in APP/tTA mice from 3 days after
dox removal for both Aβ40 and Aβ42 (Fig. 3d-e; p < 10
− 4
for all time points after dox removal). Thus, we show that
removal of dox from the diet resulted in a rapid and highly
significant increase in both APP expression and Aβ levels.
A comparison of Aβ levels between developmental-onset
APP/tTA mice and time-of-expression matched mature-
onset 12 weeks-off-dox mice showed a surprising seven-
fold increase in Aβ40 levels and a twenty-fold increase in
Aβ42 levels in developmental-onset APP/tTA mice com-
pared to expression-matched mature-onset APP/tTA mice
(Aβ40: Fig. 3d; two way ANOVA: genotype F(1,24) = 66.97, p
< 10− 4; time of expression onset F(1,24) = 54.95, p < 10
− 4;
genotype x time of expression onset F(1,24) = 46.42, p < 10
−
4, Aβ42: Fig. 3e; two way ANOVA: genotype F(1,24) = 61.37,
p < 10− 4; time of expression onset F(1,24) = 52.85, p < 10
− 4;
genotype x time of expression onset F(1,24) = 51.69, p < 10
−
4). This suggests stronger concentration-dependent Aβ
effects in developmental-onset line 102 mice.
Spatial working memory deficits in mature-onset APP/TTA
mice following 3 weeks of APPSw,Ind expression
We next investigated the effects of inducible, mature-onset,
APP expression and Aβ accumulation on hippocampus
dependent spatial working memory using spontaneous al-
ternation behavior in the T-maze [17]. We observed a
Fig. 2 Developmental onset APP/tTA mice display impaired basal synaptic transmission but normal long term potentiation. a Input-output response was
reduced in the CA3-CA1 pathway of developmental onset APP/tTA mice compared to control littermates (control n = 15, APP/tTA n = 15). Scale bar
calibration: 5ms, 0.5mV. b Reduced paired-pulse response in developmental onset APP/tTA mice (control mean = 2 ± 0.05, n= 14; APP/tTA mean 1.8 ±
0.07, n = 14). Scale bar calibration: 10ms, 0.2 mV. c TBS-induced LTP (arrowhead) was similar between developmental onset control and APP/tTA mice. d
End LTP value, averaged 50–60min after TBS, showed that APP/tTA mice exhibit a similar level of LTP to control littermates (control mean= 138.6 ± 11.2,
n= 12; APP/tTA mean 145.6 ± 15.4, n = 12). fEPSP example traces shown for time points immediately before (thin line) and 60min after (thick line) LTP
induction. Scale bar calibration: 5ms, 0.5 mV
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significant interaction between genotype and duration of
APPSw,Ind expression (two-way ANOVA: F(3,101) = 5.82, p =
0.001). We found that APP/tTA mice born and raised on
dox since conception (always-on-dox), had alternation
scores comparable to those of littermate controls (Fig. 4a;
t-test: t(32) = 0.78, p = 0.44). Similarly, APP/tTA mice taken
off the dox diet for 2 weeks performed equally as well as
control littermates (Fig. 4b; t-test: t(26) = 1.61, p = 0.12). In
contrast, APP/tTA mice taken off dox for 3 weeks had
significantly lower spontaneous alternation scores com-
pared to control littermates (Fig. 4c; t-test: t(26) = 2.42, p =
0.023). A further reduction in spontaneous alternation
scores was observed in APP/tTA mice that were taken off
the dox diet for 12 weeks (Fig. 4d; t-test: t(17) = 3.24, p =
0.0048). Thus, our results show that 3 weeks of APPSw,Ind
expression, but not 2 weeks, is sufficient to drive a progres-
sive deficit in hippocampal dependent spatial working
memory in the T-maze.
Fig. 3 Induction of APP expression and increase in Aβ following dox removal in mature mice. a Experimental timeline showing time points at
which APP expression and Aβ levels were measured. Hippocampal lysates were obtained from 12 week-old mice expressing the APPSw,Ind
transgene from postnatal development (developmental onset) and from mature-onset mice reared on dox to suppress APPSw,Ind expression
throughout life (0 days) and in mice 3 days, 2 weeks, 3 weeks and 12 weeks after dox removal. b Representative Western blots probing for APP
expression (6E10) in WT, APP, tTA and APP/tTA mice at the different time points tested. GAPDH was used as a loading control. c Normalised APP
signal intensity showed a significant effect of time of dox removal (control genotypes n = 9 for all time points, APP/tTA genotype n = 3 for all
time points). d A rapid increase in Aβ40 was observed in APP/tTA mice following dox removal (control n = 9, APP/tTA n = 3 for all time points
except 12 weeks where APP/tTA n = 7). e A rapid increase in Aβ42 was observed in APP/tTA mice following dox removal (control n = 9, APP/tTA n
= 3 for all time points except 12 weeks where APP/tTA n = 7)
Sri et al. Acta Neuropathologica Communications            (2019) 7:25 Page 8 of 20
Mature-onset APP/tTA mice exhibit thigmotaxic behavior
in the Morris water maze at 2 weeks-off-dox
Next, we assessed MWM performance in the mature-onset
line 102 model. First, we assessed the effects of baseline
APP transgene leakage by studying 8-week-old mice kept
always-on-dox. We found that these APP/tTA mice per-
formed similarly to controls during acquisition (Fig. 5a; RM
ANOVA: genotype F(1,10) = 0.05, p= 0.82; training block
F(7,70) = 7.20, p < 10
− 4; genotype x training block F(7,70) =
1.45, p= 0.2) and the probe trial (Fig. 5b; t-test: t(10) = 0.73,
p= 0.48). These results showed that baseline performance in
the MWM was similar for control and APP/tTA animals
born and raised on the dox diet.
To analyze early effects of APPSw,Ind expression we next
assessed MWM performance in mice taken off the dox
diet at 6 weeks of age for 2 weeks (Fig. 5c-e). Analysis of
latency to platform during training showed that APP/tTA
mice took longer to reach the hidden platform compared
to controls (Fig. 5c; RM ANOVA: genotype F(1,10) = 13.28,
p = 0.0045; training block F(7,70) = 25.44, p < 10
− 4; geno-
type x training block F(7,70) = 3.63, p = 0.0021), and a simi-
lar pattern of results was observed for path lengths (data
not shown; RM ANOVA: genotype F(1,10) = 9.43, p = 0.05;
training block F(7,70) = 15.90, p < 10
− 4; genotype x training
block F(7,70) = 3.41, p = 0.01).
Notably, on the very first trial we also observed a
highly significant effect of genotype on thigmotaxic
behaviour (Fig. 5e; F(1,10) = 19.62, p = 0.0013), indicating
basal differences prior to learning. Thigmotaxic behavior
decreased with training and closely paralleled reductions in
latency scores. By the end of training, both groups were es-
caping rapidly from the water with equivalent latencies and
after the final training block both APP/tTA mice and con-
trol littermates spent a similar amount of time in the plat-
form quadrant during the probe trial (Fig. 5d; t-test: t(10) =
0.32, p = 0.76). Our results show that mature-onset APP/
tTA mice that expressed APP for 2 weeks show increased
thigmotaxic behavior in the MWM, they were able to learn
the platform location and achieve a similar level of per-
formance to controls by the end of training, as previously
observed in mature-onset line 102 mice [23]. We cannot,
however ascertain whether the observed differences in
MWM performance during the early stages of training in
this experiment are due to a learning deficit on this task
given the confounding factors of thigmotaxis.
A progressive decline in spatial reference memory in
mature-onset APP/tTA mice after dox withdrawal
Given this potentially confounding thigmotaxis pheno-
type we observed in the MWM, we also assessed spatial
reference memory using the Y-water maze. We found
that mature-onset APP/tTA mice, expressing APPSw,Ind
for 2 weeks, performed similarly to littermate controls
Fig. 4 Emergence of spatial working memory deficit on the T-maze. a APP/tTA mice reared on dox to suppress APPSw,Ind throughout life performed
similar to control littermates (control mean = 79.1 ± 3.07, n = 17; APP/tTA mean = 82.2 ± 2.57, n = 17). Dashed line represents chance level performance
of 50%. b Spontaneous alternation score was similar between APP/tTA mice expressing APPSw,Ind for 2 weeks (2weeks-off-dox) and control littermates
(control mean = 77.7 ± 3.06, n = 16; APP/tTA mean = 84.3 ± 2.34, n = 12). c A reduced spontaneous alternation score was observed in APP/tTA mice
expressing APPSw,Ind for 3 weeks (3-weeks-off-dox; control mean = 85.1 ± 1.44, n = 14; APP/tTA mean = 77.3 ± 2.89, n = 14). d APP/tTA mice expressing
APPSw,Ind for 12 weeks (12 weeks-off-dox) exhibited reduced alternation scores compared to control littermates (control mean = 84.1 ± 3.83, n = 8; APP/
tTA mean = 67.5 ± 3.38, n = 11)
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during both acquisition training (Fig. 6a; RM ANOVA:
genotype F(1,10) = 0.011, p = 0.92; training block F(8,80) =
7.08, p < 10− 4; genotype x training block F(8,80) = 0.22, p
= 0.99) and the probe trial (Fig. 6b; t-test: t(10) = 2.08, p
= 0.065). Similar results were obtained for mature-onset
mice expressing APPSw,Ind for 3 weeks-off-dox (Fig. 6c-d;
acquisition RM ANOVA: genotype F(1,21) = 0.013, p =
0.91; training block F(8,168) = 11.21, p < 10
− 4; genotype x
training block F(8,168) = 1.89, p = 0.065; probe t-test: t(21)
= 1.29, p = 0.21). In contrast, we observed a significant
effect of genotype in the acquisition phase for
mature-onset APP/tTA mice at 12 weeks-off-dox (Fig.
6f; RM ANOVA: genotype F(1,27) = 4.44, p = 0.045; train-
ing block F(8,216) = 7.21, p < 10
− 4; genotype x training
block F(8,216) = 1.63, p = 0.12). Furthermore, during the
probe trial we found that mature-onset APP/tTA mice
that expressed APPSw,Ind for 12 weeks spent less time in
the goal arm compared to control littermates (Fig. 6f;
t-test: t(27) = 2.07, p = 0.048). When comparing the probe
test results for all three time points we found an inter-
action between genotype and duration of APPSw,Ind expres-
sion (two-way ANOVA: genotype F(1,58) = 0.90, p = 0.35;
length of APP expression F(2,58) = 2.86, p = 0.065; genotype
x length of APP expression F(2,58) = 4.23, p = 0.019). Thus,
we show here an emerging deficit in spatial reference
memory in mature-onset mice and that 12 weeks of
mature-onset APPSw,Ind expression is sufficient to cause a
deficit in the Y-water maze task.
A deficit in basal synaptic transmission at CA3/CA1
synapses is evident in mature-onset APP/tTA mice
following 12 weeks of APPSw,Ind expression
We then characterized the emergence of synaptic defi-
cits in mature-onset line 102 mice by performing field
recordings at CA3-CA1 synapses in hippocampal
slices. I-O curves were used to measure baseline syn-
aptic transmission. Firstly, we analyzed 10–13 week--
old mice born and reared continuously on the dox diet
(always-on-dox) to assess any baseline effects of trans-
gene leakage. We found that there was no significant
effects of genotype in I-O responses between APP/tTA
mice and control littermates (Fig. 7a; RM ANOVA:
genotype F(1,10) = 0.85, p = 0.38; stimulation F(7,70) =
Fig. 5 Mature-onset APP/tTA mice exhibit thigmotaxic behavior on the Morris water maze. a Analysis of latency to platform showed that APP/tTA
mice reared on dox (always on dox) performed similar to control littermates (control n = 6, APP/tTA n = 6). b Probe trial performed at the end of
water maze testing showed no significant difference in time spent within the target quadrant (control mean = 48.7 ± 6.72; APP/tTA mean = 55.4 ±
6.32). Dashed line represents chance level performance of 25%. c APP/tTA mice expressing APPSw,Ind for 2 weeks (2 weeks-off-dox) were slower to
reach the platform compared to control littermates (control n = 6, APP/tTA n = 6). d Probe trial showed that APP/tTA mice expressing APPSw,Ind
for 2 weeks spent a similar percentage of time in the platform quadrat as control littermates (control mean = 45 ± 9.82; APP/tTA mean = 41.2 ±
6.79). e Thigmotaxis analysis showed that APP/tTA mice expressing APPSw,Ind for 2 weeks were more thigmotaxic compared to control littermates
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26.44, p < 10− 4; genotype x stimulation amplitude
F(7,70) = 1.17, p = 0.33).
I-O responses were also comparable between control
mice and APP/tTA mice expressing the APPSw,Ind trans-
gene for 2 weeks or 3 weeks with no effect of genotype (2
weeks, Fig. 7b; RM ANOVA: genotype F(1,12) = 0.33, p =
0.58; stimulation F(7,84) = 45.88, p < 10
− 4; genotype x stimu-
lation F(7,84) = 0.16, p = 0.99; 3 weeks, Fig. 7c; RM ANOVA:
genotype F(1,14) = 2.03, p = 0.18; stimulation F(7,98) = 41.71,
p < 10− 4; genotype x stimulation F(7,98) = 1.13, p = 0.35). By
12 weeks of APPSw,Ind expression, however, the I-O
responses of APP/tTA mice were significantly reduced
compared to littermate controls (Fig. 7d; RM ANOVA:
genotype F(1,20) = 1.44, p = 0.24; stimulation F(7,140) = 74.82,
p < 10− 4; genotype x stimulation F(7,140) = 4.32, p = 0.0002).
To further investigate the progressive impairment of basal
synaptic transmission, we also analyzed mice expressing
APPSw,Ind for 29 weeks (Fig. 7e) and observed an even big-
ger reduction in the size of the fEPSPs for a given stimula-
tion intensity, with both an effect of genotype (F(1,10) = 7.70,
p = 0.02) and an interaction between genotype and stimula-
tion amplitude (F(7,70) = 10.45, p < 10
− 4).
We also measured paired pulse facilitation as an indi-
cator of presynaptic function. We found that the PPF
response in APP/tTA mice was comparable to control
littermates for mice that were always-on-dox (Fig. 8a;
t-test: t(10) = 0.23, p = 0.82) and for those expressing the
APP transgene for 2 weeks (Fig. 8b; t-test: t(12) = 0.21, p
= 0.84), 3 weeks (Fig. 8c; t-test: t(14) = 1.96, p = 0.077),
and 12 weeks (Fig. 8d; t-test: t(20) = 0.52, p = 0.61). In
contrast, at the most advanced time point of 29 week-
s-off-dox, we did find a significant impairment in PPF
responses (Fig. 8e; t-test: t(10) = 3.96, p = 0.0027). Thus
at 29 weeks-off dox we observe a dysregulation of both
pre- and post-synaptic function.
Synaptic plasticity is impaired in mature-onset APP/tTA
mice after 3 weeks of APPSw,Ind expression
We also assessed synaptic plasticity in the CA3-CA1 path-
way and found that the amount of LTP induced was simi-
lar between APP/tTA and control mice born and raised
continually on the dox diet (Fig. 9a-b; t-test: t(10) = 1.11, p
= 0.29), indicating no effect of transgene leakage. LTP
levels were also comparable between mature-onset APP/
tTA mice expressing APPSw,Ind for 2 weeks and control lit-
termates (Fig. 9c-d; t-test: t(10) = 1.03, p = 0.33), despite the
substantial increase in APP, and Aβ levels (Fig. 3). In
marked contrast, however, following 3 weeks of APPSw,Ind
expression, we then observed a substantial reduction in
LTP in mature-onset APP/tTA mice compared to control
littermates (Fig. 9e-f; t-test: t(12) = 3.99, p = 0.0018).
Impaired LTP was also observed in mature-onset APP/
tTA mice expressing the APPSw,Ind transgene for 12
weeks-off-dox (Fig. 9g-h; t-test: t(16) = 4.37, p = 0.0005)
and 29 weeks-off-dox (Fig. 9i-j; t-test: t(10) = 2.47, p =
0.033).
Thus, we show that 3 weeks of APPSw,Ind expression is
sufficient to drive a significant deficit in synaptic plasti-
city in the mature-onset line 102 model, which coincides
with the emergence of a spatial working memory deficit
(Fig. 4c). Interestingly, this deficit precedes the signifi-
cant impairment in basal synaptic transmission and
spatial reference memory that were observed at 12 week-
s-off-dox (Fig. 7). Notably, there were no significant
differences between the magnitude of LTP deficit in
mature-onset APP/tTA mice between 3 and 12 weeks
(t-test: t(13) = 0.29, p = 0.78), 3 and 29 weeks (t-test: t(10)
= 1.35, p = 0.21) and 12 and 29 weeks (t-test: t(13) = 1.69,
p = 0.11), indicating that the maximum LTP impairment
is evident from 3 weeks-off-dox.
Early deficit in synaptic plasticity can be reversed by
suppressing APPSw,Ind expression
Previous work has shown that Aβ disrupts synaptic pro-
tein scaffolds by activating intracellular pathways that
promote synapse disassembly: observed as a reduction in
PSD thickness [49] and underpinned by a dispersal of
PSD components [44] prior to neurodegeneration. We
hypothesised that the earliest deficit in synaptic plasticity
observed in mature-onset APP/tTA mice (Fig. 9e-f ) after
3 weeks of Aβ accumulation expression might be revers-
ible, and that switching off APPSw,Ind expression would
be sufficient to restore synaptic plasticity. Mice were
therefore taken off dox at six weeks of age and allowed
to express the APPSw,Ind transgene for 3.5 weeks. Follow-
ing this, mice were put back on the dox diet for 9–11
weeks before being tested at 18–20 weeks of age
(Fig. 10a, “Reversibility group” on the experimental
timeline).
We assessed total levels of Aβ40 and Aβ42 in hippocam-
pal lysates of APP/tTA mice from the reversibility group
and control littermates (Fig. 10b-c), and compared these
against age-matched mature-onset mice that expressed the
APPSw,Ind transgene for 12 weeks (Fig. 3d-e, 12 weeks-off--
dox). As expected, putting APP/tTA mice back on the dox
diet caused a significant reduction in Aβ40 (Fig. 10b; two
way ANOVA: genotype F(1,24) = 23.72, p < 10
− 4; dox diet
F(1,24) = 16.69, p = 0.0004; genotype x dox diet F(1,24) =
21.21, p = 0.0001) and Aβ42 (Fig. 10c; two way ANOVA:
genotype F(1,24) = 33.14, p < 10
− 4; dox diet F(1,24) = 35.41, p
< 10− 4; genotype x dox diet F(1,24) = 32.83, p < 10
− 4), back
to the levels found in control littermates.
We next sought to assess if this reduction in Aβ levels
was sufficient to rescue the observed deficit in synaptic
plasticity seen in mature-onset APP/tTA mice following
3 weeks of APPSw,Ind expression (Fig. 10d-e). Following
TBS, both APP/tTA mice from the reversibility group
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and control littermates in interleaved experiments exhib-
ited similar LTP (Fig. 10d-e; t-test: t(12) = 0.26, p = 0.80).
Thus, the early deficit in synaptic plasticity observed fol-
lowing 3 weeks of APPSw,Ind expression (Fig. 9e-f ) is re-
versible. Importantly, inhibiting further APP expression
and Aβ accumulation also prevented the progressive
reduction in baseline synaptic transmission and I-O def-
icit observed in mature-onset mice expressing APPSw,Ind
for 12 weeks. APP/tTA mice from the reversibility group
also exhibited normal I-O (Fig. 10f; RM ANOVA: geno-
type F(1,14) = 0.77, p = 0.40; stimulation F(7,98) = 37.92, p <
10− 4; genotype x stimulation F(7,98) = 0.64, p = 0.72) and
Fig. 6 Emergence of spatial reference memory deficit on the Y-water maze. a APP/tTA mice expressing APPSw,Ind for 2 weeks (2 weeks-off-dox) performed
similarly to control littermates (control n = 6, APP/tTA n = 6). Dashed line represents chance level of performance of 50%. b Probe trial performed at the
end of water maze training showed APP/tTA mice performed slightly, but not significantly, better than control littermates (control mean = 51.9 ± 2.81; APP/
tTA mean = 63.4 ± 4.75). Dashed line represents chance level of performance of 33.3%. c Analysis of acquisition showed that APP/tTA mice expressing
APPSw,Ind for 3weeks (3 weeks-off-dox) performed similarly to control littermates (control n = 14, APP/tTA n = 9). d Probe trial showed that APP/tTA mice
performed similar to control littermates (control mean = 47 ± 4.74; APP/tTA mean = 55.3 ± 2.87). e RM-ANOVA analysis of acquisition showed that APP/tTA
mice expressing APPSw,Ind for 12weeks (12weeks-off-dox) showed an effect of genotype but no interaction between genotype and block (control n = 16,
APP/tTA n = 13). f Probe trial results showed that APP/tTA mice expressing APPSw,Ind for 12weeks spent a significantly lower percentage time within the
goal arm compared to control littermates (control mean = 51.9 ± 3.38; APP/tTA mean = 42.2 ± 3.10)
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PPF responses (Fig. 10g; t-test: t(14) = 0.65, p = 0.53) com-
pared to control littermates.
Thus, our mature-onset data show that in APP/tTA
mice, synaptic and cognitive deficits appear progres-
sively: synaptic plasticity and spatial working memory
are first affected, and then impairment of basal synaptic
transmission and spatial reference memory emerge later.
Unlike mature-onset APP/tTA mice expressing APP for
12 weeks, developmental onset APP/tTA mice expressing
APP for 12weeks show normal spatial reference memory
in the Y-maze escape task and normal CA3-CA1 synaptic
plasticity, despite showing deficits in basal synaptic
transmission and working memory. Our results demon-
strate that despite expressing the APPSw,Ind transgene for a
similar length of time, there are key and substantial differ-
ences between mature-onset and developmental onset
expression.
Discussion
Although the precise time of onset of AD is ill-defined, it is
increasingly recognized that understanding the early events
in disease progression may lead to more effective thera-
peutic interventions [24, 28, 58]. Here we have used the
inducible line 102 model to map the emergence of
Fig. 7 Emergence of a deficit in input-output response in CA3-CA1 synapses. a No significant differences between input-output response in APP/tTA mice
reared on dox and control littermates (control n = 6, APP/tTA n= 6). b Normal input-output response in APP/tTA mice expressing APPSw,Ind for 2weeks
(control n = 7, APP/tTA n = 7). c Normal input-output response in APP/tTA mice expressing APPSw,Ind for 3weeks (control n = 8, APP/tTA n= 8). d Reduced
input-output response in APP/tTA mice expressing APPSw,Ind for 12weeks (control n = 11, APP/tTA n= 11). e Reduced input-output response in APP/tTA mice
expressing APPSw,Ind for 29weeks (control n = 6, APP/tTA n= 6). Scale bar calibration: 5ms, 0.5mV
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Aβ-mediated cognitive and synaptic deficits [23, 71]. We
firstly addressed the differences between developmental-
onset and mature-onset overexpression of APP and Aβ.
We found that although there were similar levels of APP
expression in both models expressing APPSw,Ind for 12
weeks, it was not possible to match exactly the Aβ expres-
sion levels in developmental-onset and mature-onset mice;
Aβ40 levels were seven fold and Aβ42 levels were twenty
fold higher in developmental-onset mice. These results add
support to the evidence for differences in APP processing
mechanisms between the neonatal and adult brain [8].
Importantly, the inducible line 102 model provided a
gradual increase of Aβ at physiologically relevant
concentrations which are within the pM range observed in
postmortem AD brain tissue [39, 40].
Developmental-onset mice showed a substantial dis-
ruption of basal synaptic transmission consistent with
previous studies in several APP lines [16, 31, 33]. Never-
theless, similar to other young-adult developmental APP
models, we found that despite high levels of Aβ, devel-
opmental onset APP/tTA mice exhibited normal levels
of NMDAR-dependent hippocampal LTP in CA3-CA1
synapses (which was inhibited by APV, data not shown)
[13, 19, 26, 27, 32, 42]. These results are in stark contrast
to the impaired LTP we observed in mature-onset mice
with a similar duration of APP expression, and even though
Fig. 8 Emergence of a deficit in paired-pulse response in CA3-CA1 synapses. a Paired-pulse response was similar in APP/tTA and control mice reared on
dox (control mean = 2.1 ± 0.13, n = 6; APP/tTA mean = 2.0 ± 0.18, n = 6). b Normal paired-pulse response in APP/tTA mice expressing APPSw,Ind transgene
for 2 weeks (control mean = 2.0 ± 0.11, n = 7; APP/tTA mean = 2.0 ± 0.08, n = 7). c Normal paired-pulse response in APP/tTA mice expressing APPSw,Ind
transgene for 3 weeks (control mean = 2.0 ± 0.06, n = 8; APP/tTA mean = 1.7 ± 0.12, n = 8). d Normal paired-pulse response in APP/tTA mice expressing
APPSw,Ind for 12weeks (control mean = 1.8 ± 0.07, n = 11; APP/tTA mean = 1.7 ± 0.07, n = 11). e Impaired paired-pulse response in APP/tTA mice
expressing APPSw,Ind for 29 weeks (control mean = 1.9 ± 0.06, n = 6; APP/tTA mean = 1.6 ± 0.07, n = 6). Scale bar calibration: 10ms, 0.2mV
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Fig. 9 (See legend on next page.)
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there were lower Aβ levels in the mature-onset model. In-
deed, a stronger inhibition of LTP would be expected from
a higher dose of Aβ in vivo present in the
developmental-onset mice [25]. These results suggest either
compensation or reduced vulnerability to expression of
APPSw,Ind and Aβ in young brains. Previous research shows
that there are important age-dependent differences in signal
transduction cascades for LTP [70] which can render hip-
pocampal LTP insensitive to acute Aβ application in post-
natal mice [62]. The highly plastic brains of developing
mice (Daw et al. 2008) may be able to prevent the immedi-
ate effects of Aβ and may be able to adapt their plasticity
mechanisms to long term exposure, as shown by our nor-
mal LTP results in 12week developmental onset mice.
However, it is clear that basal synaptic transmission is still
impaired in developmental-onset animals (Fig. 2c-d). Con-
versely, it is possible that once this period of developmental
plasticity has passed there is a decreasing capacity for the
brain to functionally compensate for damage caused by Aβ
as demonstrated by the persistent loss of LTP in our
mature-onset model up to 29 weeks-off-dox. Further re-
search will be required to test whether the synapse loss
mechanisms in developmental-onset vs mature-onset mice
are the same and whether the differences in these reflect
the mechanisms of synapse loss in familial and sporadic
AD, respectively.
Developmental onset line 102 mice (12 weeks of age)
performed poorly in the MWM (Fig. 1b-d). Their acqui-
sition and probe trial readouts were highly impaired.
They performed at chance levels, similar to other devel-
opmental APP models [48, 69]. However, on further in-
spection of the data we observed a highly thigmotaxic
phenotype which could contribute to their MWM def-
icit. This was also evident in mice with 2-weeks-off-dox
expression. It was thus not possible to determine
whether there was a genuine learning impairment in the
open field watermaze paradigm, independent of the
effects of thigmotaxis. However, when tested with an
alternative hippocampal-dependent, spatial reference
memory task which is unaffected by thigmotaxis
(Y-water maze), APP/tTA mice acquired the task as well
as control littermates. Taken together, these behavioural
results highlight the potential influence that levels of
thigmotaxis can have on water maze acquisition and per-
formance [43].
Our results suggest that the residual hippocampal syn-
aptic function and plasticity in developmental-onset
mice is able to support performance in a long-term
memory task in the Y-Water maze. Moreover, despite
normal levels of LTP in developmental onset APP mice,
we observed highly impaired CA3-CA1 basal synaptic
transmission. This deficit could underpin the impaired
performance in alternation in the T-maze given the high
sensitivity of this task to hippocampal dysfunction [4]. In
contrast to developmental onset mice, our analysis of
mature-onset APP expressing mice, shows that that hip-
pocampal synaptic plasticity is greatly diminished follow-
ing 3 weeks of APPSw,Ind expression whereas basal
synaptic transmission is not affected until later –follow-
ing 12–29 weeks of APPSw,Ind expression. The sequence
of events we have described here, suggests that a lack of
LTP in the mature-onset model would potentially lead
to lower synaptic transmission over time. The decrease
in paired pulse facilitation we observe, both in the devel-
opmental model and at 29-weeks-off-dox, may reflect a
compensatory effect of enhanced presynaptic release
probability as a result of reduced basal transmission.
Notably, the loss of plasticity we observed at 3-week-
s-off-dox shares some similarities with results from acute
application of nanomolar Aβ concentrations onto acute
hippocampal slices which blocked LTP, without affecting
basal synaptic transmission [56, 63, 65]. However, the nor-
mal plasticity we observed at 2-weeks-off-dox after a grad-
ual increase of Aβ to pM levels is at odds with the acute
effect of Aβ within hours of a step change to nM concen-
trations. The gradual increase of Aβ reaching chronic pM
concentrations may allow for early compensation given the
capacity of neural circuits for physiological adaptations
such as homeostatic plasticity mechanisms [46, 59] which
may differ in developmental-onset and mature-onset ani-
mals. Further analysis will be required to test whether these
compensatory mechanisms are at play and their relevance
to human synapses when CSF Aβ levels change prior to
and during plaque deposition in AD [9, 61]. Moreover, it
(See figure on previous page.)
Fig. 9 Emergence of a deficit in synaptic plasticity in CA3-CA1 synapses. a TBS-induced LTP (arrowhead) was similar between control and APP/tTA mice
reared on dox (always-on-dox). b End LTP value, averaged 50–60min after TBS, showed that APP/tTA mice reared on dox exhibited a similar level of LTP
to control littermates (control mean = 168.1 ± 11.74, n = 6; APP/tTA mean = 152.1 ± 8.34, n = 6). Example traces are shown for time points immediately
before (thin line) and 60min after (thick line) LTP induction. c TBS-induced LTP was normal in APP/tTA mice expressing APPSw,Ind for 2 weeks (2 weeks-
off-dox). d APP/tTA mice expressing APPSw,Ind for 2 weeks exhibited a similar LTP response as control littermates (control mean = 141.2 ± 8.46, n = 6; APP/
tTA mean = 159.0 ± 14.66, n = 6). e TBS-induced LTP was impaired in APP/tTA mice expressing APPSw,Ind for 3 weeks (3 weeks-off-dox). f End LTP response
was lower in APP/tTA expressing APPSw,Ind for 3 weeks (control mean = 169.1 ± 9.09, n = 8; APP/tTA mean = 115.4 ± 9.69, n = 6). g TBS-induced LTP was
impaired in APP/tTA mice expressing APPSw,Ind for 12 weeks (12 weeks-off-dox). h End LTP response was lower in APP/tTA expressing APPSw,Ind for 12
weeks (control mean = 156.5 ± 7.75, n = 9; APP/tTA mean = 118.0 ± 4.17, n = 9). i TBS-induced LTP was reduced in APP/tTA mice expressing APPSw,Ind for
29weeks (29weeks-off-dox). j End LTP response was lower in APP/tTA expressing APPSw,Ind for 29 weeks (control mean = 174.7 ± 15.06, n = 6; APP/tTA
mean = 132.2 ± 8.24, n = 6). Labels in a apply to all LTP plots in figure. Scale bar calibration: 5ms, 0.5mV
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would be of interest to analyse whether the age of onset of
APP expression in line 102 mice (e.g. mature-onset vs
ageing-onset) can have an impact on the emergence and
progression of cognitive and synaptic impairment.
We observed a dissociation between CA3-CA1 LTP
levels and spatial reference memory performance in
mature-onset animals. Mice with 3 weeks of mature-onset
APP expression, exhibited normal Y-water maze acquisi-
tion and performance during the subsequent probe trial,
despite impaired LTP. Although the idea that
activity-dependent modification of synaptic strength pro-
vides a neural substrate for learning and memory has been
intensively investigated for many years [10, 37], the precise
relationships between different forms of synaptic plasticity
Fig. 10 Suppressing APP expression and Aβ levels allows recovery of LTP deficit in APP/tTA mice. a Experiment timeline; mice allocated to the reversibility
group expressed APPSw,Ind for 3.5 weeks before being put back on the dox diet for 9–11weeks to suppress further APPSw,Ind expression. b Aβ40 levels in
hippocampal lysates of APP/tTA mice from the reversibility group were similar to control genotype levels. In comparison, shaded area shows levels of Aβ40
for age-matched APP/tTA mice from the 12weeks-off-dox group (12weeks-off-dox: control n = 9, APP/tTA n = 7; Reversibility study: control n = 6, APP/tTA
n = 6). c Aβ42 levels in hippocampal lysates of APP/tTA mice from the reversibility group returned to control levels. Shaded area shows levels of Aβ42 for
APP/tTA mice from the age-matched 12weeks-off-dox group (12weeks-off-dox: control n = 9, APP/tTA n = 7; Reversibility study: control n = 6, APP/tTA n
= 6). d TBS-induced LTP (arrowhead) was similar between control and APP/tTA mice from the reversibility study group. e End LTP values, averaged 50–60
min after TBS, were similar between control and APP/tTA mice from the reversibility study group (control mean = 148.0 ± 16.86, n = 7; APP/tTA mean =
142.6 ± 12.24, n = 7). LTP trace shown for time points immediately before (thin line) and 60min after (thick line) LTP induction. Scale bar calibration for LTP
trace: 5ms, 0.5mV. f A similar input-output response was observed in the CA3-CA1 pathway of control and APP/tTA mice from the reversibility study
(control n = 8, APP/tTA n = 8). Scale bar calibration for input-output trace: 5ms, 0.5mV. g Paired-pulse response was similar between control and APP/tTA
mice from the reversibility group (control mean = 1.5 ± 0.08, n = 8; APP/tTA mean = 1.6 ± 0.12, n = 8). Scale bar calibration for paired-pulse
traces: 10 ms, 0.2 mV
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and different aspects of memory performance remain to
be fully resolved [3]. Nevertheless, NMDAR dependent
synaptic plasticity plays an important role in short term
memory processes that may contribute to spatial working
memory performance [3, 50] and the 3 weeks-off-dox
mice exhibited a spatial working memory deficit in spon-
taneous alternation in the T-maze which proved the more
sensitive measure of the emergent cognitive decline [4,
50]. Notably, working memory deficits are a key feature of
early Alzheimer’s disease –whereby impairment in the
“registration, storage, and retrieval of new information”
that impairs daily living is essential for diagnosis [34],
while long term memory is more associated with ad-
vanced AD stages. This suggests that line 102 is a suitable
mouse model for the emergence of AD that could guide
further mechanistic analyses and therapeutic testing.
A number of strategies are being pursued to lower Aβ
levels and reverse their effects in the brain [23, 54, 67]. We
show here that by increasing and then subsequently de-
creasing APP expression and de novo Aβ production, we
were able to reverse the early deficits in LTP we had ob-
served previously. Interestingly, we found that reversing the
LTP deficit also prevented the subsequent reduction in
basal synaptic transmission (Fig. 10d-g). Although our ex-
periments do not determine whether loss of plasticity and
synapse loss in the mature-onset model are causally related,
our data suggest that the loss of LTP could be either a pre-
cursor or driver of the subsequent loss of synaptic input
manifested as a reduction in I-O curves. Thus, our findings
suggest that loss of synaptic plasticity is a very early event
that could ultimately underpin both short and long mem-
ory loss in the line 102 mature-onset model, and therefore
understanding the mechanisms of LTP impairment in this
model could guide us in the search for therapeutic targets
in early AD.
Although very little is known regarding the loss of
plasticity in the human brain in AD, one study [5]
found that plasticity following paired associative stimu-
lation is already impaired in individuals with mild to
moderate AD. This suggests that the loss of synaptic
plasticity we observe in mature-onset line 102 mice is
relevant to the early phase of disease and given its re-
versibility, that it may be amenable to pharmacological
intervention. It will be of interest to discover if and
when these synaptic deficits are no longer reversible in
mice, and then in humans [64] in order to time neuro-
protective interventions accordingly. Thus, our work
provides a platform to further dissect the cellular
mechanisms that underpin early cognitive deficits and
loss of plasticity in early AD [60].
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